Runx2 induces bone osteolysis by transcriptional suppression of TSSC1

Biochemical and Biophysical Research Communications

Volumn 438, Issue 4, 2013, Pages 635-639

  Wang, Da Chuan ^a   Wang, Hai Feng ^a   Yuan, Ze Nong ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Breast cancer; Osteolytic lesions; Runx2; TSSC1

Indexed keywords

TRANSCRIPTION FACTOR RUNX2; TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; BONE LESION; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT;

BREAST CANCER; OSTEOLYTIC LESIONS; RUNX2; TSSC1;

ANIMALS; BONE AND BONES; BONE NEOPLASMS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; OSTEOLYSIS; UP-REGULATION;

EID: 84883267574     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.131     Document Type: Article

References (26)

1. Shore P. A role for Runx2 in normal mammary gland and breast cancer bone metastasis. J. Cell. Biochem. 2005, 96:484-489.
2. Pratap J., Lian J.B., Stein G.S. Metastatic bone disease: role of transcription factors and future targets. Bone 2011, 48:30-36.
3. Pratap J., Javed A., Languino L.R., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 2005, 25:8581-8591.
4. Thomas D.M., Johnson S.A., Sims N.A., Trivett M.K., Slavin J.L., Rubin B.P., Waring P., McArthur G.A., Walkley C.R., Holloway A.J., Diyagama D., Grim J.E., Clurman B.E., Bowtell D.D., Lee J.S., Gutierrez G.M., Piscopo D.M., Carty S.A., Hinds P.W. Terminal osteoblast differentiation, mediated by Runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell Biol. 2004, 167:925-934.
5. Nathan S.S., Pereira B.P., Zhou Y.F., Gupta A., Dombrowski C., Soong R., Pho R.W., Stein G.S., Salto-Tellez M., Cool S.M., van Wijnen A.J. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma. Mol. Biol. Rep. 2009, 36:153-158.
6. Wang X., Manner P.A., Horner A., Shum L., Tuan R.S., Nuckolls G.H. Regulation of MMP-13 expression by Runx2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 2004, 12:963-973.
7. Mendoza-Villanueva D., Deng W., Lopez-Camacho C., Shore P. The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells. Mol. Cancer 2010, 9:171.
8. Pratap J., Wixted J.J., Gaur T., Zaidi S.K., Dobson J., Gokul K.D., Hussain S., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008, 68:7795-7802.
9. Clines G.A., Guise T.A. Molecular mechanisms and treatment of bone metastasis. Expert Rev. Mol. Med. 2008, 10:e7.
10. Robinson D.R., Zylstra C.R., Williams B.O. Wnt signaling and prostate cancer. Curr. Drug Targets 2008, 9:571-580.
11. Emami K.H., Corey E. When prostate cancer meets bone: control by Wnts. Cancer Lett. 2007, 253:170-179.
12. Hall C.L., Keller E.T. The role of Wnts in bone metastases. Cancer Metastasis Rev. 2006, 25:551-558.
13. Guarino M. Src signaling in cancer invasion. J. Cell. Physiol. 2010, 223:14-26.
14. Zhang H., Pan Y., Zheng L., Choe C., Lindgren B., Jensen E.D., Westendorf J.J., Cheng L., Huang H. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 2011, 71:3257-3267.
15. Pratap J., Lian J.B., Javed A., Barnes G.L., van Wijnen A.J., Stein J.L., Stein G.S. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 2006, 25:589-600.
16. Cai D., Cao J., Li Z., Zheng X., Yao Y., Li W., Yuan Z. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC Cancer 2009, 9:102.
17. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., Zaidi S.K., Young D.W., Choi J.Y., Pockwinse S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
18. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell. Biochem. 2006, 99:1233-1239.
19. Baniwal S.K., Khalid O., Gabet Y., Shah R.R., Purcell D.J., Mav D., Kohn-Gabet A.E., Shi Y., Coetzee G.A., Frenkel B. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol. Cancer 2010, 9:258.
20. Akech J., Wixted J.J., Bedard K., van der Deen M., Hussain S., Guise T.A., van Wijnen A.J., Stein J.L., Languino L.R., Altieri D.C., Pratap J., Keller E., Stein G.S., Lian J.B. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 2010, 29:811-821.
21. Leong D.T., Lim J., Goh X., Pratap J., Pereira B.P., Kwok H.S., Nathan S.S., Dobson J.R., Lian J.B., Ito Y., Voorhoeve P.M., Stein G.S., Salto-Tellez M., Cool S.M., van Wijnen A.J. Cancer-related ectopic expression of the bone-related transcription factor Runx2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res. 2010, 12:R89.
22. Chimge N.O., Baniwal S.K., Little G.H., Chen Y.B., Kahn M., Tripathy D., Borok Z., Frenkel B. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2. Breast Cancer Res. 2011, 13:R127.
23. Guise T.A. Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. Genes Dev. 2009, 23:2117-2123.
24. Pratap J., Imbalzano K.M., Underwood J.M., Cohet N., Gokul K., Akech J., van Wijnen A.J., Stein J.L., Imbalzano A.N., Nickerson J.A., Lian J.B., Stein G.S. Ectopic Runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression. Cancer Res. 2009, 69:6807-6814.
25. Boras-Granic K., Wysolmerski J.J. PTHrP and breast cancer: more than hypercalcemia and bone metastases. Breast Cancer Res. 2012, 14:307.
26. Danilin S., Merkel A.R., Johnson J.R., Johnson R.W., Edwards J.R., Sterling J.A. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology 2012, 1:1484-1494.